Literature DB >> 9886671

The metabotropic glutamate receptor 1 is not involved in the facilitation of glutamate release in cerebrocortical nerve terminals.

A Sistiaga1, I Herrero, F Conquet, J Sánchez-Prieto.   

Abstract

In this study we have addressed the identification of the metabotropic glutamate receptor (mGluR) involved in the facilitation of glutamate release in nerve terminals from the cerebral cortex. mGluR1 and 5 are coupled to phosphoinositide hydrolysis and the activation of these receptors with the specific agonist 3,5-dihydroxyphenylglycine (DHPG) enhances the release of glutamate. We have examined whether mGluR1 is responsible for this modulatory effect by preparing nerve terminals from mGluR 1 deficient mice. The Ca2+-dependent glutamate release evoked by a submaximal depolarization is enhanced by the agonist DHPG in nerve terminals from both wild and mutant mice. This result is consistent with the finding that the mGluR agonist also induces a similar increase in the levels of diacylglycerol (DAG) in the nerve terminals from wild and mutant mice. Moreover, the activity-dependent switch from facilitation to inhibition of release, observed when a second stimulation of the receptor is applied shortly after (5 min) the first pulse, was also observed in the mutant mice. These results indicate therefore, that the facilitation of glutamate release is unlikely to be due to the activation of mGluR1 but related to another phosphoinositide coupled mGluR.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9886671     DOI: 10.1016/s0028-3908(98)00129-4

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  8 in total

1.  Dendritic and axonal targeting of type 5 metabotropic glutamate receptor is regulated by homer1 proteins and neuronal excitation.

Authors:  F Ango; J P Pin; J C Tu; B Xiao; P F Worley; J Bockaert; L Fagni
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

2.  Presynaptic mGlu1 and mGlu5 autoreceptors facilitate glutamate exocytosis from mouse cortical nerve endings.

Authors:  Veronica Musante; Elisa Neri; Marco Feligioni; Aldamaria Puliti; Marco Pedrazzi; Valerio Conti; Cesare Usai; Alberto Diaspro; Roberto Ravazzolo; Jeremy M Henley; Giuseppe Battaglia; Anna Pittaluga
Journal:  Neuropharmacology       Date:  2008-07-03       Impact factor: 5.250

3.  Activation of metabotropic glutamate 5 (mGlu5) receptors induces spontaneous excitatory synaptic currents in layer V pyramidal cells of the rat prefrontal cortex.

Authors:  Gerard J Marek; Ce Zhang
Journal:  Neurosci Lett       Date:  2008-07-04       Impact factor: 3.046

4.  Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells.

Authors:  I Sarnico; F Boroni; M Benarese; S Sigala; A Lanzillotta; L Battistin; P Spano; M Pizzi
Journal:  J Neural Transm (Vienna)       Date:  2007-12-19       Impact factor: 3.575

Review 5.  Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies.

Authors:  Irina Esterlis; Sophie E Holmes; Priya Sharma; John H Krystal; Christine DeLorenzo
Journal:  Biol Psychiatry       Date:  2017-09-19       Impact factor: 13.382

Review 6.  Presynaptic Release-Regulating mGlu1 Receptors in Central Nervous System.

Authors:  Anna Pittaluga
Journal:  Front Pharmacol       Date:  2016-08-31       Impact factor: 5.810

7.  Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression.

Authors:  I Esterlis; N DellaGioia; R H Pietrzak; D Matuskey; N Nabulsi; C G Abdallah; J Yang; C Pittenger; G Sanacora; J H Krystal; R V Parsey; R E Carson; C DeLorenzo
Journal:  Mol Psychiatry       Date:  2017-04-11       Impact factor: 15.992

Review 8.  Presynaptic Release-regulating Metabotropic Glutamate Receptors: An Update.

Authors:  Guendalina Olivero; Matteo Vergassola; Francesca Cisani; Alessandra Roggeri; Anna Pittaluga
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.